CA2489214C - Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers - Google Patents
Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers Download PDFInfo
- Publication number
- CA2489214C CA2489214C CA2489214A CA2489214A CA2489214C CA 2489214 C CA2489214 C CA 2489214C CA 2489214 A CA2489214 A CA 2489214A CA 2489214 A CA2489214 A CA 2489214A CA 2489214 C CA2489214 C CA 2489214C
- Authority
- CA
- Canada
- Prior art keywords
- aurora
- protein
- antibody
- hybridomas
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR02/07212 | 2002-06-12 | ||
| FR0207212A FR2840905B1 (fr) | 2002-06-12 | 2002-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
| PCT/FR2003/001772 WO2003106500A1 (fr) | 2002-06-12 | 2003-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2489214A1 CA2489214A1 (fr) | 2003-12-24 |
| CA2489214C true CA2489214C (fr) | 2013-08-06 |
Family
ID=29595167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2489214A Expired - Lifetime CA2489214C (fr) | 2002-06-12 | 2003-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7514231B2 (ja) |
| EP (1) | EP1511771B1 (ja) |
| JP (1) | JP4555681B2 (ja) |
| AT (1) | ATE420115T1 (ja) |
| AU (1) | AU2003255671A1 (ja) |
| CA (1) | CA2489214C (ja) |
| DE (1) | DE60325725D1 (ja) |
| FR (1) | FR2840905B1 (ja) |
| WO (1) | WO2003106500A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| SG175609A1 (en) | 2006-10-09 | 2011-11-28 | Takeda Pharmaceutical | Kinase inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0868519T3 (da) * | 1995-12-18 | 2006-05-08 | Sugen Inc | Diagnose og behandling af AUR-1- og/eller AUR-2-relaterede lidelser |
-
2002
- 2002-06-12 FR FR0207212A patent/FR2840905B1/fr not_active Expired - Lifetime
-
2003
- 2003-06-12 AT AT03760023T patent/ATE420115T1/de not_active IP Right Cessation
- 2003-06-12 JP JP2004513330A patent/JP4555681B2/ja not_active Expired - Lifetime
- 2003-06-12 US US10/517,645 patent/US7514231B2/en not_active Expired - Lifetime
- 2003-06-12 CA CA2489214A patent/CA2489214C/fr not_active Expired - Lifetime
- 2003-06-12 AU AU2003255671A patent/AU2003255671A1/en not_active Abandoned
- 2003-06-12 WO PCT/FR2003/001772 patent/WO2003106500A1/fr active Application Filing
- 2003-06-12 EP EP03760023A patent/EP1511771B1/fr not_active Expired - Lifetime
- 2003-06-12 DE DE60325725T patent/DE60325725D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE420115T1 (de) | 2009-01-15 |
| FR2840905A1 (fr) | 2003-12-19 |
| WO2003106500A1 (fr) | 2003-12-24 |
| EP1511771A1 (fr) | 2005-03-09 |
| FR2840905B1 (fr) | 2006-07-07 |
| JP4555681B2 (ja) | 2010-10-06 |
| EP1511771B1 (fr) | 2009-01-07 |
| JP2006513135A (ja) | 2006-04-20 |
| DE60325725D1 (de) | 2009-02-26 |
| US20070117163A1 (en) | 2007-05-24 |
| AU2003255671A1 (en) | 2003-12-31 |
| AU2003255671A8 (en) | 2003-12-31 |
| US7514231B2 (en) | 2009-04-07 |
| CA2489214A1 (fr) | 2003-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3561268B2 (ja) | レセプターチロシンキナーゼ標的タンパク質のｃＤＮＡクローニング方法及びｈＧＲＢタンパク質 | |
| Wong et al. | The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction | |
| Egerton et al. | VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. | |
| JPH09506250A (ja) | Ｒｓｅと命名される蛋白チロシンキナーゼ | |
| US7744882B2 (en) | Soluble ErbB3 methods of detection and antibodies | |
| JPH09510861A (ja) | 新規な蛋白質チロシンホスファターゼに対するヌクレオチド配列の一次構造および機能性発現 | |
| AU2001263952B2 (en) | Tumour suppressor and uses thereof | |
| AU2001263952A1 (en) | Tumour suppressor and uses thereof | |
| CA2489214C (fr) | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers | |
| JPH09508795A (ja) | Ｍａｐ キナーゼ ホスファターゼ及びそれらをコードする核酸の生産並びに使用 | |
| US5677421A (en) | Target proteins for eukaryotic tyrosine kinases | |
| US7871786B2 (en) | GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof | |
| US6770467B2 (en) | Screening method for ligands with class II P13 kinase modulating activity | |
| JP4719831B2 (ja) | Ｔｐｌ−２／ｃｏｔキナーゼおよび使用方法 | |
| JPH10117788A (ja) | ヒト・ｍｙｔ−１キナーゼクローン | |
| EP0960337B1 (en) | Cathepsin K and breast cancer | |
| JP2007517502A (ja) | 活性なｋｉｔチロシンキナーゼ受容体のモジュレーターを同定する方法 | |
| US5840536A (en) | Growth factor receptor-binding insulin receptor | |
| WO1997012971A1 (en) | Ring finger protein | |
| JPH09327292A (ja) | プロテインキナーゼｎの改変タンパク質 | |
| JP2004073142A (ja) | Ｇａｎｐ結合性タンパク質 | |
| WO1997020573A1 (en) | Growth factor receptor-binding protein 2 homolog | |
| JP2002355070A (ja) | タウ−チューブリンキナーゼをコードするｄｎａ及びその利用 | |
| WO1997048809A1 (en) | LIGASE ISOLATED FROM $i(MYCOBACTERIUM AVIUM) | |
| CA2528844A1 (fr) | Nouvelles sequences phosphorylees de la phosphatase cdc25b, anticorps diriges contre ces sequences ainsi que leur utilisation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20230612 |